Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-07-01 Purchase | 2024-07-03 8:04 pm | Rapport Therapeutics Inc. | RAPP | HEALY JAMES Director | 44,032 | $24.52 | $1,079,575 | 1,922,819 (Indirect) | View |
| 2024-06-10 Purchase | 2024-06-10 7:38 pm | Rapport Therapeutics Inc. | RAPP | HEALY JAMES Director | 558,824 | $17 | $9,500,008 | 25,455 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-10 Conversion | 2024-06-10 7:46 pm | N/A N/A | Rapport Therapeutics Inc. | RAPP | ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner | 35,652,876 | $0 | 3,728,738 (Indirect) | View |
| 2024-06-06 Option Award | 2024-06-10 7:44 pm | N/A 2034-06-05 | Rapport Therapeutics Inc. | RAPP | Galer Bradley S. Chief Medical Officer | 123,818 | $0 | 123,818 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-10 7:43 pm | N/A 2034-06-05 | Rapport Therapeutics Inc. | RAPP | Gault Cheryl Chief Operations Officer | 88,442 | $0 | 88,442 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-10 7:43 pm | N/A 2034-06-05 | Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer | 28,302 | $0 | 28,302 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-10 7:42 pm | N/A 2034-06-05 | Rapport Therapeutics Inc. | RAPP | Yeleswaram Krishnaswamy Chief Development Officer | 84,904 | $0 | 84,904 (Direct) | View |
| 2024-06-10 Conversion | 2024-06-10 7:42 pm | N/A N/A | Rapport Therapeutics Inc. | RAPP | Third Rock Ventures V L.P. Third Rock Ventures GP V LP TRV GP V LLC Third Rock Ventures VI L.P. Third Rock Ventures GP VI L.P. TRV GP VI LLC 10% Owner | 71,909,947 | $0 | 8,104,451 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-10 7:39 pm | N/A 2034-06-05 | Rapport Therapeutics Inc. | RAPP | Ceesay Abraham Chief Executive Officer | 530,647 | $0 | 530,647 (Direct) | View |
| 2024-06-10 Conversion | 2024-06-10 7:38 pm | N/A N/A | Rapport Therapeutics Inc. | RAPP | HEALY JAMES Director | 13,316,876 | $0 | 25,455 (Indirect) | View |
| 2024-06-06 Option Award | 2024-06-10 7:35 pm | N/A 2034-06-05 | Rapport Therapeutics Inc. | RAPP | Ignelzi Troy A. Chief Financial Officer | 81,366 | $0 | 81,366 (Direct) | View |
Ownership | 2024-06-06 7:14 pm | N/A N/A | Rapport Therapeutics Inc. | RAPP | ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner | 0 | $0 | 3,728,738 (Indirect) | View |
Ownership | 2024-06-06 7:07 pm | N/A N/A | Rapport Therapeutics Inc. | RAPP | Galer Bradley S. Chief Medical Officer | 0 | $0 | 290,861 (Direct) | View |
Ownership | 2024-06-06 7:04 pm | N/A N/A | Rapport Therapeutics Inc. | RAPP | Gault Cheryl Chief Operations Officer | 0 | $0 | 290,861 (Direct) | View |
Ownership | 2024-06-06 7:03 pm | N/A N/A | Rapport Therapeutics Inc. | RAPP | HEALY JAMES Director | 0 | $0 | 1,392,738 (Indirect) | View |
Ownership | 2024-06-06 7:03 pm | N/A N/A | Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer | 0 | $0 | 673,624 (Direct) | View |
Ownership | 2024-06-06 6:59 pm | N/A N/A | Rapport Therapeutics Inc. | RAPP | Yeleswaram Krishnaswamy Chief Development Officer | 0 | $0 | 432,747 (Direct) | View |
Ownership | 2024-06-06 6:57 pm | N/A N/A | Rapport Therapeutics Inc. | RAPP | Third Rock Ventures V L.P. Third Rock Ventures GP V LP TRV GP V LLC Third Rock Ventures VI L.P. Third Rock Ventures GP VI L.P. TRV GP VI LLC 10% Owner | 0 | $0 | 8,104,451 (Direct) | View |
Ownership | 2024-06-06 6:56 pm | N/A 2034-03-24 | Rapport Therapeutics Inc. | RAPP | MARAGANORE JOHN Director | 0 | $0 | 87,567 (Direct) | View |
Ownership | 2024-06-06 6:52 pm | N/A 2034-01-12 | Rapport Therapeutics Inc. | RAPP | Burrell Terry-Ann Director | 0 | $0 | 35,027 (Direct) | View |
Ownership | 2024-06-06 6:51 pm | N/A N/A | Rapport Therapeutics Inc. | RAPP | PAUL STEVEN M Director | 0 | $0 | 644,036 (Direct) | View |
Ownership | 2024-06-06 6:49 pm | N/A N/A | Rapport Therapeutics Inc. | RAPP | Ceesay Abraham Chief Executive Officer | 0 | $0 | 1,307,854 (Direct) | View |
Ownership | 2024-06-06 6:46 pm | N/A 2033-12-05 | Rapport Therapeutics Inc. | RAPP | Ignelzi Troy A. Chief Financial Officer | 0 | $0 | 436,585 (Direct) | View |